Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

The front entrance to the Kennedy building © David Fisher

The Kennedy Institute of Rheumatology was delighted to receive two awards from the Oxford Preservation Trust, which celebrates the contribution that buildings and environmental projects make to the city’s character. The new roof extension won the 2021 Green Award for Sustainability as well as being awarded a Certificate in the New Building category.

It was designed by Fathom Architects to target ambitious PassivHaus EnerPHit standards and included features for airtightness, minimising thermal bridging and the use of triple glazing.

One of the key considerations was the energy efficiency of the building. To minimise the impact of cooling, glazing was replaced by fixed panels, external louvres and internal blinds. Insulation was added behind the non-transparent parts of the wall to improve its thermal performance. The roof has also been future-proofed with the structure designed to accommodate photo voltaic panels to be installed at a later stage.

The features were incorporated while maintaining the aesthetic of the original building.

Chairman of the Awards Panel, The Rev Prof William Whyte remarked that the sustainability standards reached were an “extraordinarily difficult thing to do with laboratories.”

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.